Supplements > Improving Provider and Patient Acceptance of Biosimilars in Treating Cancer: Clinical, Manufacturing, and Cost Considerations

Supplements - Improving Provider and Patient Acceptance of Biosimilars in Treating Cancer: Clinical, Manufacturing, and Cost Considerations

June 26, 2018 – Steven Lucio, PharmD, BCPS
June 26, 2018 – Carina Dolan, PharmD, BCOP
June 26, 2018
June 26, 2018
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.